Registration open for second annual Staff Professional Development Week

2022 events take place Feb. 28-March 4

University leaders will kick off Staff Professional Development Week  on Monday, Feb. 28, 2-3 p.m., with keynote speaker, Olympic gold medalist Mary Wineberg, CECH ‘02, as she encourages us all to achieve our own dreams.

full schedule of workshops will follow March 1-4, providing opportunities to learn new skills, indulge in self-care and engage in professional relationship building. You can add sessions you’re interested in directly to your calendars from the Staff Senate site

Live captioning will be provided at all sessions (requests for other accessibility related accommodations can be made by emailing hrlearning@uc.edu no later than Feb. 21).

Staff Professional Development Week is a collaboration between the Staff Success Center, Staff Senate, and Central HR as part of the Staff Enrichment Pathway. All events will be held virtually due to COVID concerns.

If you or other staff need access to computers to attend sessions, please reach out to the Staff Success Center at hrlearning@uc.edu to sign up to use one of the computer labs to attend.

Related Stories

1

UC faculty and staff among Rising Star leadership honorees

January 5, 2026

Two UC faculty and staff members are among this year's Rising Star leadership program sponsored by YWCA Greater Cincinnati. Kelli Beecher, assistant professor in the UC College of Nursing, and Brittany Bibb, assistant director of programs and operations in the UC Division of Student Affairs, are among the emerging leaders of 2026. They were featured in the publication Movers & Makers.

2

What's behind the mysterious rise of migraines?

January 5, 2026

Weather patterns such as extreme heat and storm conditions have been linked to migraine attacks, and research shows those environmental conditions are becoming more common. As National Geographic recently reported, one of the leading theories behind this mysterious rise is that climate change may be playing a role.

3

Top six 2025 nephrology drug approvals

January 5, 2026

“2025 has been a landmark year for kidney disease therapeutics, marked by a comprehensive slate of FDA approvals covering endothelin-receptor blockade, complement inhibition, GLP-1-based metabolic protection, and B-cell-directed therapy,” Prakash Gudsoorkar, MD, associate professor of clinical medicine at the University of Cincinnati College of Medicine and staff nephrologist at UC Health, recently told MedCentral.